Retention Rate For A Rural Mobile Telemedicine Treatment Unit Plus Buprenorphine Equivalent To Office-Based Treatment Retention

The three-month opioid treatment retention rate for a rural telemedicine mobile treatment unit (TM-MTU) plus buprenorphine was not statistically different to the retention rate for office-based treatment. The three-month retention rate for the MTU was 58.5%. In comparison, the three-month retention rate for those in an evaluation of both TM-MTU and non-TM-MTU treatment was approximately 75.4%. Longer retention was significantly associated with reduced opioid use.

Opioid use for those in TM-MTU dropped by about 32.8% from baseline. Compared with the nearest in-person treatment location, the telemedicine TM . . .